Marco Mastrodonato

BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then.

Sinclair Pharma Plc is a specialty pharmaceutical company. It provides solutions to treat wounds, which include skin disinfection, radiation dermatitis treatment and wounds and burns healing; dermatology, which include fungal infections, acne, atopic dermatitis and family dermatology; as well as oral diseases, which include gingivitis, periodontitis, mouth ulcers and teething through advanced surface technology and innovative delivery systems. The company was founded by Andrew Sinclair in 1971 and is headquartered in Godalming, the United Kingdom.